Skip to main content
. 2019 Jan 8;80(6):632–639. doi: 10.1055/s-0038-1676768

Table 1. Study characteristics.

Ref. First Author PY Lang Pts. in Study Pts. Used Reason for pt. removal Outcomes Measures
37 Aschendorff 2017 E 8 5 CI not placed SDS
38 Bohr 2017 G 6 5 NF2 PAT, SDS
39 DeHart 2017 E 1 1 PAT, AzBio, CNC
40 Plontke 2017 E 12 5 CI not placed SDS
41 Carlson 2016 E 10 3 NF2 PAT, AzBio, CNC
42 Dagna 2016 E 1 1 PTA, HINT, THI
21 Hassepass 2016 E 11 3 CI not placed or no CI outcomes HINT, localization test, tinnitus VAS, subjective survey
43 Huo 2016 E 3 2 C/l CI placement PAT, SDS mono/di/sentence, THI, telephone use
44 Kim 2016 E 2 2 PAT, HINT
45 Schipper 2017 G 10 10 SDS
46 Schutt 2014 E 1 1 PAT, SDS
47 Di Lella 2013 E 10 3 C/l CI placement Disyllabic SDS, sentence recognition
48 Helbig 2009 E 1 1 SDS
49 Zanetti 2008 E 1 1 SDS
50 Arriaga 1995 E 1 1 PAT

Abbreviations: AzBio, Arizona biomedical institute sentence test; CI, cochlear implant; CNC, Maryland consonant-vowel nucleus-consonant test; E, English; G, German; HINT, hearing in noise test; Lang., language; NF2, neurofibromatosis type 2; PAT, postimplant audiometry threshold; Pt, patients; Pts, patients; C/I, contralateral; Ref, reference number; SDS, speech discrimination score; THI, tinnitus handicap index; VAS, visual analog scale.